Effectiveness of Different Methods in Acute Myofascial Pain Syndrome

Completed

• Conditions: Myofacial Pain Syndromes

• Registration Number: NCT04827303
• Lead Sponsor: Ufuk University

Brief Summary

This study is a randomized controlled study. A total of 75 patients between the ages of 20-50 who have a diagnosis of acute myofacial pain syndrome in the trapezius muscle and have pain for a maximum of 5 days were included in the study. Patients were randomly divided into 3 groups. Group 1 patients received kinesio tape method (25 patients), group 2 patients received trigger point injection method (25 patients), and group 3 patients received neural therapy injection method (25 patients). A 10-15 cm sized I band was applied to the trapezius muscles of the first group patients with the patient's neck in lateral flexion. Then, while the patient's neck is flexed, a Y-shaped 15-20 cm tape will be affixed between C1-7 with the arms of the Y up, and I tape of 5-10 cm is attached on the arms. In group 2 patients, 1 cc lidocaine diluted with 4 cc saline (SF) was applied to the trigger points palpated manually in the trapezius muscles. After the trigger point was squeezed between the thumb and index finger, a few cc of local anesthetic mixture was applied into the trigger point with the injector and exited. In the 3rd group patients, a few cc local anesthetic mixture will be applied intradermally over the trigger point without entering into the trigger points palpated manually in the trapezius muscles. Patients were checked 72 hours and 1 week after the first applications.

The pain at rest and during movement of the patients in all 3 groups were evaluated with a visual analog scale (VAS 10 cm). The number of trigger points was determined by the physician by hand palpation. Pressure pain threshold was evaluated with the algometer device. Disability assessment of the patients was made using the neck pain disability index. evaluations were made at the beginning of treatment, 72 hours after and 1 week after treatment.

Detailed Description

Not available

Study Timeline

• Study Start: 2017-04-01
• Primary Completion: 2019-04-01
• Study Completion: 2019-04-01
• Status Verified: 2021-03
• Study First Submitted: 2021-03-29
• Study First Submitted QC: 2021-03-29
• Last Update Submitted: 2021-03-29
• Study First Posted: 2021-04-01
• Last Update Posted: 2021-04-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 75

Inclusion Criteria

• Patients diagnosed with acute myofascial pain syndrome
• Patients between the ages of 20-50
• Patients with pain for up to 5 days

Exclusion Criteria

• Patients diagnosed with fibromyalgia
• Patients with systemic disease
• Patients with prominent cervical disc herniation
• Patients with cervical arthrosis
• Patients with cervical radiculopathy and myelopathy
• Patients with myofascial trigger point injection in the past 6 months
• Patients who received physical therapy in the past 6 months
• Patients undergoing shoulder and neck surgery
• Patients with drug allergies

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Visual analog scale	1 week	The pain at rest and during movement of the patients in all 3 groups were evaluated with a visual analog scale (VAS 10 cm).
The number of trigger points	1 week	The number of trigger points was determined by the physician by hand palpation.
Neck pain disability index	1 week	Disability assessment of the patients was made using the neck pain disability index.
Pressure pain threshold	1 week	Pressure pain threshold was evaluated with the algometer device.

Trial Locations

Locations (1)

Ufuk University; 🇹🇷 Ankara, Turkey